ANKYLOSING SPONDYLITIS

This study tested whether an injectable medication called bimekizumab could help people with active ankylosing spondylitis, a painful inflammatory arthritis of the spine. Over 300 participants received either the drug or a placebo for 16 weeks to see if it could reduce symptoms l…

This study followed 127 adults for two years to see how well they stayed on a prescribed drug called secukinumab, which treats several related inflammatory conditions. Researchers tracked whether patients continued treatment and measured changes in their symptoms, pain, and quali…

This study tested whether adding methotrexate to the standard drug adalimumab helps reduce the body's immune reaction against the treatment in people with ankylosing spondylitis. Researchers enrolled 110 adults with active spinal arthritis who hadn't responded well to common anti…

This study tested whether an intravenous medication called golimumab could reduce symptoms of active ankylosing spondylitis, a chronic inflammatory disease that causes back pain and stiffness. 208 participants were randomly assigned to receive either the drug or a placebo infusio…

This study tested whether a non-invasive, focused ultrasound treatment could reduce harmful inflammation in people with inflammatory arthritis. Sixteen participants, including healthy volunteers and people with conditions like rheumatoid arthritis, received several ultrasound ses…

This study tested whether an investigational drug called AK111 could reduce symptoms and improve quality of life for people with active ankylosing spondylitis, a painful inflammatory arthritis of the spine. Over 500 participants were randomly assigned to receive either AK111 or a…

This study observed how well and how safely the approved drug RINVOQ worked for adults with ankylosing spondylitis in real-world medical settings in Japan. About 70 participants who were prescribed RINVOQ by their doctors were followed for up to one year. The main goal was to tra…

This completed Phase 3 study tested whether a new injectable medication called netakimab could help control active ankylosing spondylitis, a painful inflammatory arthritis of the spine. It involved 113 Chinese adult patients who had not gotten enough relief from standard anti-inf…

This study looked at whether switching patients to a higher concentration version of the drug adalimumab (brand name SIMLANDI™) causes less injection site pain than the standard version. It involved 324 adults in Canada who were already using adalimumab for conditions like Crohn'…

This study tested whether adding wet cupping therapy to standard medication helps people with ankylosing spondylitis. One hundred adults with the condition were split into two groups: one received medication plus three monthly cupping sessions, while the other received only medic…

This study tested whether adding kinesiology tape to standard home exercises helps people with ankylosing spondylitis more than exercises alone. Researchers enrolled 63 adults with this chronic back condition and split them into two groups. One group did home exercises, while the…

This study tested whether a personalized physical training program could help people with ankylosing spondylitis, a condition that causes painful stiffness in the spine and joints. 56 participants were randomly assigned to either follow the exercise program or just receive inform…

This study aimed to find a better way to measure how quickly the spine stiffens and fuses in people with ankylosing spondylitis, a form of arthritis. Researchers compared detailed CT scans to regular X-rays to see which method could detect changes in bone growth more accurately o…

This study aimed to understand how a person's genes might influence how severe their ankylosing spondylitis becomes over time. Researchers followed about 300 adults with this spinal arthritis for five years, checking their symptoms and mobility every six months. The goal was to i…

This study aimed to understand how erectile dysfunction is related to pain, disease activity, and treatment in men with ankylosing spondylitis, a chronic inflammatory back disease. Researchers observed and compared 90 men across three groups: those on anti-TNF therapy, those on s…